JP Morgan Maintains Underweight on RXO, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Brian Ossenbeck maintains an Underweight rating on RXO (NYSE:RXO) and raises the price target from $25 to $26.
August 08, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
JP Morgan analyst Brian Ossenbeck maintains an Underweight rating on RXO but raises the price target from $25 to $26.
The Underweight rating suggests a bearish outlook, but the slight increase in the price target indicates some positive expectations. The net impact is likely neutral in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100